84 related articles for article (PubMed ID: 2730904)
1. Liposome-dependent delivery of pteridine antifolates: a two-compartment growth inhibition assay for evaluating drug leakage and metabolism.
Ng KY; Heath TD
Biochim Biophys Acta; 1989 Jun; 981(2):261-8. PubMed ID: 2730904
[TBL] [Abstract][Full Text] [Related]
2. Liposome-mediated delivery of pteridine antifolates to cells in vitro: potency of methotrexate, and its alpha and gamma substituents.
Heath TD; Lopez NG; Piper JR; Montgomery JA; Stern WH; Papahadjopoulos D
Biochim Biophys Acta; 1986 Nov; 862(1):72-80. PubMed ID: 3768370
[TBL] [Abstract][Full Text] [Related]
3. Leakage and delivery of liposome-encapsulated methotrexate-gamma-aspartate in a chemically defined medium.
Comiskey SJ; Heath TD
Biochim Biophys Acta; 1990 May; 1024(2):307-17. PubMed ID: 2354182
[TBL] [Abstract][Full Text] [Related]
4. The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma-aspartate to cells in vitro.
Heath TD; Lopez NG; Papahadjopoulos D
Biochim Biophys Acta; 1985 Oct; 820(1):74-84. PubMed ID: 3876848
[TBL] [Abstract][Full Text] [Related]
5. Serum-induced leakage of negatively charged liposomes at nanomolar lipid concentrations.
Comiskey SJ; Heath TD
Biochemistry; 1990 Apr; 29(15):3626-31. PubMed ID: 2340262
[TBL] [Abstract][Full Text] [Related]
6. LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs.
Amin K; Ng KY; Brown CS; Bruno MS; Heath TD
Pharm Res; 2001 Jul; 18(7):914-21. PubMed ID: 11496949
[TBL] [Abstract][Full Text] [Related]
7. Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate.
Heath TD; Montgomery JA; Piper JR; Papahadjopoulos D
Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1377-81. PubMed ID: 6572395
[TBL] [Abstract][Full Text] [Related]
8. Targeted drug delivery: a two-compartment growth inhibition assay demonstrates that fluorodeoxyuridine and fluorodeoxyuridine monophosphate are liposome-independent drugs.
Heath TD; Brown CS
Sel Cancer Ther; 1989; 5(4):179-84. PubMed ID: 2533702
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell proliferation and dihydrofolate reductase by liposomes containing methotrexate-dimyristoylphosphatidylethanolamine derivatives and by the glycerophosphorylethanolamine analogs.
Hashimoto K; Loader JE; Knight MS; Kinsky SC
Biochim Biophys Acta; 1985 Jun; 816(1):169-78. PubMed ID: 4005236
[TBL] [Abstract][Full Text] [Related]
10. Drug interactions: pteridine diuretics and antifols. II. In vivo studies.
Hall TC; Godsill A; Wodinsky I
J Clin Pharmacol J New Drugs; 1968; 8(4):219-24. PubMed ID: 5242161
[No Abstract] [Full Text] [Related]
11. Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-gamma-dimyristoylphosphatidylethanolamine.
Noé C; Hernandez-Borrell J; Kinsky SC; Matsuura E; Leserman L
Biochim Biophys Acta; 1988 Dec; 946(2):253-60. PubMed ID: 3207742
[TBL] [Abstract][Full Text] [Related]
12. In vitro drug delivery mediated by ecto-NAD+-glycohydrolase ligand-targeted liposomes.
Salord J; Schuber F
Biochim Biophys Acta; 1988 Sep; 971(2):197-206. PubMed ID: 3167100
[TBL] [Abstract][Full Text] [Related]
13. New methodology for liposome targeting to specific cells.
Papahadjopoulos D; Heath T; Bragman K; Matthay K
Ann N Y Acad Sci; 1985; 446():341-8. PubMed ID: 2861775
[TBL] [Abstract][Full Text] [Related]
14. Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition.
Berinstein N; Matthay KK; Papahadjopoulos D; Levy R; Sikic BI
Cancer Res; 1987 Nov; 47(22):5954-9. PubMed ID: 3664498
[TBL] [Abstract][Full Text] [Related]
15. Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.
Matthay KK; Heath TD; Papahadjopoulos D
Cancer Res; 1984 May; 44(5):1880-6. PubMed ID: 6713389
[TBL] [Abstract][Full Text] [Related]
16. Liposome dependent delivery of S-adenosyl methionine to cells by liposomes: a potential treatment for liver disease.
Wagner EJ; Krugner-Higby L; Heath TD
J Pharm Sci; 2009 Feb; 98(2):573-82. PubMed ID: 18642386
[TBL] [Abstract][Full Text] [Related]
17. Effect of liposomes sensitized with methotrexate-gamma-dimyristoylphosphatidylethanolamine on cells that are resistant to methotrexate.
Kinsky SC; Hashimoto K; Loader JE; Knight MS; Fernandes DJ
Biochim Biophys Acta; 1986 Feb; 885(2):129-35. PubMed ID: 3484974
[TBL] [Abstract][Full Text] [Related]
18. Differential distribution of liposome-entrapped [3H]methotrexate and labelled lipids after intravenous injection in a primate.
Kimelberg HK
Biochim Biophys Acta; 1976 Nov; 448(4):531-50. PubMed ID: 823974
[TBL] [Abstract][Full Text] [Related]
19. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
[TBL] [Abstract][Full Text] [Related]
20. LDL-induced association of anionic liposomes with cells and delivery of contents. II. Interaction of liposomes with cells in serum-containing medium.
Amin K; Heath TD
J Control Release; 2001 May; 73(1):49-57. PubMed ID: 11337059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
